+41.1%
GSK vs VSH
+13.4%
+27.7%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -10.7% | +10.6% | +0.2% |
| 7D | -5.3% | -16.0% | +10.7% | -4.9% |
| 30D | -3.7% | -25.2% | +21.5% | -3.1% |
| 3M | -7.3% | -29.5% | +22.3% | -6.6% |
| 6M | -4.2% | -44.1% | +39.8% | -3.9% |
| YTD | +0.9% | +55.9% | -55.1% | -8.1% |
| 1Y | +7.3% | +92.5% | -85.3% | -4.2% |
| 3Y | +52.7% | +4.6% | +48.2% | +41.1% |
| All | +41.1% | +13.4% | +27.7% | +24.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VSH.
Daily Out/Under-Performance
Portfolio return minus VSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling